论文部分内容阅读
随着医学科学的发展,在治疗乙型肝炎方面免疫调节剂、抗病毒治疗愈来愈受到重视,通过对用甘利欣、胸腺肽联合(A组),单用甘利欣(B组)治疗慢性乙型肝炎,观察对乙肝血清标志物的影响。现总结如下:1 材料与方法1.1 病例选择 68例慢性乙型肝炎均为我院住院病人,所有病例均符合1995年全国病毒性肝炎学术会议修订的诊断标准。所有病例HBVM检查(EIASA法)均为HBsAg(+)、HBcAb(+)、HBeAg(+);HB-
With the development of medical science, immunomodulators and antiretroviral therapy have been paid more and more attention in the treatment of hepatitis B. Through the treatment of chronic B with Glycyrrhizin, Thymosin (A group) and Glycyrrhizin alone Hepatitis B, observe the impact of hepatitis B serum markers. Are summarized as follows: 1 Materials and Methods 1.1 Case Selection 68 cases of chronic hepatitis B are inpatients in our hospital, all cases are in line with the 1995 National Viral Hepatitis Conference revised diagnostic criteria. HBsAg (+), HBcAb (+) and HBeAg (+) were detected in all cases of HBVM (EIASA method); HB-